114.05
0.24%
-0.27
Pre-market:
117.49
3.44
+3.02%
Why is Blueprint Medicines Corp (BPMC) Stock down?
02 Aug, 2023:
Shares of Blueprint Medicines (BPMC) were down more than 15.34% to $54.30 on Wednesday after the healthcare company announced second-quarter earnings. While the numbers were generally positive, investors are likely to sell on good news, taking advantage of a positive announcement, but the selling got out of hand.
https://www.fool.com/investing/2023/08/02/why-shares-of-blueprint-medicines-are-falling-wedn/
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):